US Broker Ratings

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Growth Amidst Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) remains a formidable entity in the biopharmaceutical industry, with a rich history dating back to 1887. The company’s expansive portfolio spans critical therapeutic areas such..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring Its Robust Pipeline and Analyst Ratings

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a key player in the biotechnology sector, stands out for its pioneering RNA-targeted medicines. Headquartered in Carlsbad, California, Ionis is at the forefront of developing..

Cencora, Inc. (COR) Stock Analysis: Unveiling a Promising 11.29% Potential Upside

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, is a titan in the healthcare sector, specializing in medical distribution. With a market capitalization of $69.89 billion, this Pennsylvania-based company is..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 12.68% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) is carving a niche in the highly competitive biotechnology industry, with a solid footprint in the healthcare sector. Headquartered in Minneapolis, Minnesota, the company has evolved..

UnitedHealth Group (UNH) Investor Outlook: A 31.8% Potential Upside Awaits

Investors with a keen eye on the healthcare sector may find UnitedHealth Group Incorporated (NYSE: UNH) an intriguing prospect, especially with its robust market cap of $250.6 billion and a..

Qiagen N.V. (QGEN) Stock Analysis: Healthcare Giant with a 6.89% Potential Upside

As a prominent player in the diagnostics and research sector, Qiagen N.V. (NYSE: QGEN) offers investors a robust opportunity within the healthcare industry. Headquartered in Venlo, Netherlands, this $10.5 billion..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 17.69% Upside with Strong Buy Ratings

As the investment landscape for healthcare stocks remains dynamic, Tenet Healthcare Corporation (NYSE: THC) emerges as a notable contender. With a market capitalization of $17.79 billion, Tenet has positioned itself..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Navigating a 4.35% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, is a formidable player in the drug manufacturing industry, specializing in both specialty and generic medications. With a..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling an 84.89% Potential Upside with Strong Buy Ratings

Stevanato Group S.p.A. (NYSE: STVN), a stalwart in the healthcare sector, has been drawing significant attention from the investment community. Known for its robust portfolio in medical instruments and supplies,..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader with 60% Upside Potential

Doximity, Inc. (NYSE: DOCS) is a prominent player in the health information services industry, offering a robust digital platform tailored for medical professionals. Headquartered in San Francisco, this healthcare technology..

Corcept Therapeutics (CORT) Stock Analysis: A Promising Biotech Play with 130% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has captured investor attention with its robust pipeline and significant upside potential. Specializing in the development of treatments..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Strategic Growth Potential

Baxter International Inc. (NYSE: BAX), a key player in the healthcare sector, stands as a versatile provider of medical instruments and supplies, with a robust portfolio of products spanning intravenous..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in Oncology with a 4.78% Upside

Exelixis, Inc. (NASDAQ: EXEL) stands as a prominent player in the biotechnology sector, focusing on developing groundbreaking treatments for challenging cancer types. Headquartered in Alameda, California, Exelixis has made significant..

CVS Health Corporation (CVS) Stock Analysis: A 20.94% Upside Potential Amidst Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $99.46 billion, CVS is a..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing the 14.08% Potential Upside Amidst Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, has captured investor attention with its significant market cap of $18.48 billion and a compelling potential upside of..

Ascendis Pharma (ASND) Stock Analysis: A Biotech Powerhouse with a 24.93% Upside Potential

Ascendis Pharma A/S, trading under the ticker ASND, is capturing the attention of investors with its significant growth potential in the biotechnology sector. Based in Hellerup, Denmark, Ascendis Pharma specializes..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Strategic Partnerships Drive Biotechnology Leader

For investors with a keen eye on the healthcare and biotechnology sectors, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling case, driven by its innovative technology, robust partnerships, and impressive..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering a 15.42% Potential Upside in the Healthcare Giant

Novo Nordisk A/S (NYSE: NVO), a leading player in the healthcare sector, primarily focuses on diabetes and obesity care, as well as rare diseases. With a staggering market capitalization of..

ICON plc (ICLR) Stock Analysis: Unlocking a 37% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a pivotal player in the healthcare sector, has caught the attention of investors with its robust potential upside of 37.04%. As a leading clinical research organization,..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating a 5.9% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector specializing in medical instruments and supplies, is making waves with its innovative solutions in the orthodontic industry. Known..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds